Table 2 Correlation between EBVaGC and clinico-pathological parameters
From: Characteristics of epstein barr virus variants associated with gastric carcinoma in Southern Tunisia
Clinical Characteristics | N | EBV expression* | |
|---|---|---|---|
| Â | Â | Negative (%) | Positive (%) |
Gender | Â | Â | Â |
Male | 48 | 42(87.5) | 6 (12.5) |
Female | 33 | 27(81.8) | 6 (18.2) |
p-value | Â | 0.47 | |
Age | Â | Â | Â |
< 45 | 17 | 17(100) | 0(0) |
45-60 | 30 | 21(70) | 9(30) |
> 60 | 34 | 31(91.2) | 3(8.8) |
p-value | Â | 0.009 | |
TNM | Â | Â | Â |
I-II | 9 | 9(100) | 0(0) |
III-IV | 47 | 40(87.1) | 7(14.9) |
p-value | Â | 0.216 | |
Anatomical site | Â | Â | Â |
Antrum | 48 | 41(85.4) | 7(14.6) |
Body | 22 | 19(86.4) | 3 (13.6) |
Cardia | 8 | 6(75) | 2(25) |
p-value | Â | 0.72 | |
Differentiation | Â | Â | Â |
Poor | 43 | 36(83.7) | 7 (16.3) |
   Moderate | 26 | 25(96.2) | 1 (3.8) |
Well | 9 | 6(66.7) | 3(33.3) |
p-value | Â | 0.075 | |
Lauren type | Â | Â | Â |
Intestinal | 47 | 38(80.9) | 9(19.1) |
Diffuse | 34 | 31(91.2) | 3(8.8) |
p-value | Â | 0.197 | |
Tumor size | Â | Â | Â |
< 5 cm | 9 | 8(88.9) | 1(11.1) |
> 5 cm | 65 | 54(83.1) | 11(16.9) |
p-value | Â | 0.658 | |
Venous invasion | Â | Â | Â |
Negatif | 61 | 54(88.5) | 7(11.5) |
Positif | 18 | 13(72.2) | 5(27.8) |
p-value | Â | 0.09 | |